Showing results (1631-1640 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|April 8, 2021
Prognostic Impact of the Fractionation of Total Body Irradiation for Patients with Acute Myeloid Leukemia Undergoing Myeloablative Allogeneic Hematopoietic Cell TransplantationNorihiro Ueda, Takaaki Konuma, Jun Aoki, et al.
Transplantation and Cellular Therapy|April 17, 2021
Safety of Surgical Fertility Preservation Procedures in Children Prior to Hematopoietic Stem Cell TransplantKatelynn Brodigan, Malika Kapadia, A Lindsay Frazier, et al.
Transplantation and Cellular Therapy|April 17, 2021
CD52/GPI- T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell TransplantationFrancesca A Kinsella, Charlotte F Inman, Wayne Croft, et al.
Transplantation and Cellular Therapy|February 14, 2026
Factors Associated with Prolonged Inpatient Stay in Patients undergoing Outpatient Allogeneic Stem Cell TransplantationEdward Koo, Connor Prince, David Allan, et al.
Transplantation and Cellular Therapy|January 25, 2026
Dynamic Prediction of ICU Transfer and Critical Interventions After Pediatric Allogeneic HSCTTaylor L Olson, Eduardo A Trujillo Rivera, Blachy J Dávila Saldaña, et al.
Transplantation and Cellular Therapy|January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trialJoseph Pidala, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy|January 14, 2026
Population pharmacokinetics and optimal exposure of anti-thymocyte globulin in myeloablative hematopoietic cell transplantationHamid Ghazal, Sofia Leuchter, Riley Ngo, et al.
Transplantation and Cellular Therapy|January 12, 2026
Impact of Complete Response on Long-Term Survival in Patients With Relapsed or Refractory Large B-cell Lymphoma: A CIBMTR Prospective Study and SLR/Meta-AnalysisArmin Ghobadi, Theodora Anagnostou, Jacques Azzi, et al.
Transplantation and Cellular Therapy|January 11, 2026
Cytokine-induced Killer Cell Therapy as a Post-remission Strategy in High-risk Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Prospective Investigator-Initiated Clinical StudyGi-June Min, Nayoun Kim, Keon-Il Im, et al.
Transplantation and Cellular Therapy|March 26, 2023
Pretransplant systemic metabolic profiles in allogeneic hematopoietic stem cell transplant recipients - identification of patient subsets with increased transplant-related mortalityHåkon Reikvam, Øystein Bruserud, Kimberley J Hatfield
Pageof 183